| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |